Drmitsui Foot Antifungal Treatment Spray
NDC Package 87096-004-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Drmitsui Foot Antifungal Treatment (salicylic acid) sprays is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a spray delivery system. Marketed by Zhenping Renren Industry Co., Ltd., this product is identified by NDC 87096-004 and is authorized under FDA application M005.

Identification & Billing

NDC Package Code
87096-004-01
Package Description
60 g in 1 BOTTLE, SPRAY
Product Code
87096-004
11-Digit Billing Format
87096000401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Drmitsui Foot Antifungal Treatment
Non-Proprietary Name
Salicylic Acid
Substance Name
Salicylic Acid
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Percutaneous - Administration through the skin.
Active Ingredient(s)
SALICYLIC ACID 12 g/100g
Usage Information
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

Regulatory & Marketing

Labeler Name
Zhenping Renren Industry Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M005
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-14-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87096-004-01 identifies a specific commercial package of 60 g in 1 bottle, spray of Drmitsui Foot Antifungal Treatment, a human over the counter drug labeled by Zhenping Renren Industry Co., Ltd.. This spray is formulated for percutaneous use and contains salicylic acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zhenping Renren Industry Co., Ltd. on March 14, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.

How is this Zhenping Renren Industry Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87096000401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87096-004-01
11-Digit CMS (5-4-2)
87096-0004-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.